Sick Kids Need Faster Drug Testing
January 25, 2014
Whether guided by economics or an instinct to shield children from potential harm, the way we bring new pediatric drugs to market does not always
serve the best interests of children with life-threatening illness for whom few options exist, Stephen E. Sallan, MD, writes in The Boston Globe. As a pediatric oncologist for 40 years, Sallan notes he has witnessed a revolution in cancer treatment, launched by early advances in treating children that later also benefited adults. Today, however, children with intractable disease are too often left behind and denied timely access to breakthroughs in cancer treatment that could save their lives.
Read the full story.